Tabilautide
Tabilautide is a peptide that is used in the field of pharmacology. It is a synthetic peptide that is derived from the protein parathyroid hormone (PTH). Tabilautide is primarily used in the treatment of osteoporosis, a condition that weakens bones and makes them more prone to fractures.
History[edit | edit source]
Tabilautide was first synthesized in the late 20th century as part of a broader effort to develop effective treatments for osteoporosis. The development of Tabilautide was based on the understanding of the role of PTH in bone metabolism. PTH is a hormone that regulates the levels of calcium and phosphate in the blood and promotes the growth and strengthening of bones.
Pharmacology[edit | edit source]
Tabilautide works by mimicking the effects of PTH in the body. It binds to the PTH receptor on the surface of osteoblasts, the cells responsible for bone formation. This stimulates the osteoblasts to produce more bone tissue, thereby increasing bone density and reducing the risk of fractures.
Clinical Use[edit | edit source]
Tabilautide is used in the treatment of osteoporosis in postmenopausal women who are at high risk for fracture. It is administered by subcutaneous injection. The use of Tabilautide has been shown to significantly reduce the risk of vertebral and non-vertebral fractures in women with osteoporosis.
Side Effects[edit | edit source]
Like all medications, Tabilautide can cause side effects. The most common side effects include nausea, headache, and dizziness. In rare cases, Tabilautide can cause high levels of calcium in the blood, a condition known as hypercalcemia.
Future Research[edit | edit source]
Research is ongoing to further understand the effects of Tabilautide and to explore its potential use in other conditions. For example, studies are being conducted to investigate the use of Tabilautide in the treatment of hypoparathyroidism, a condition characterized by low levels of PTH.
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
